Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 17,410 | 18,053 | 16,790 | 14,493 | 19,283 |
| Cost of Goods | 1,217 | 2,510 | 1,058 | 366 | 1,132 |
| Gross Profit | 16,193 | 15,543 | 15,732 | 14,127 | 18,151 |
| Operating Expenses | 45,451 | 49,666 | 54,513 | 51,897 | 57,932 |
| Operating Income | -29,041 | -33,613 | -38,723 | -37,404 | -39,649 |
| Interest Expense | 12,679 | 12,496 | 12,783 | 12,942 | 10,309 |
| Other Income | 5,410 | -334 | 10,728 | 2,453 | -3,462 |
| Pre-tax Income | -36,310 | -46,443 | -40,778 | -47,893 | -53,420 |
| Income Tax | 234 | 163 | 43,172 | -86 | -4,498 |
| Net Income Continuous | -36,544 | -46,606 | -83,950 | -47,807 | -48,922 |
| Net Income | $-36,544 | $-46,606 | $-83,950 | $-47,807 | $-48,922 |
| EPS Basic Total Ops | -0.38 | -0.56 | -1.03 | -0.58 | -0.60 |
| EPS Basic Continuous Ops | -0.38 | -0.56 | -1.02 | -0.58 | -0.60 |
| EPS Diluted Total Ops | -0.38 | -0.56 | -1.03 | -0.58 | -0.60 |
| EPS Diluted Continuous Ops | -0.38 | -0.56 | -1.02 | -0.58 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -0.38 | -0.56 | -1.03 | -0.58 | -0.58 |
| EBITDA(a) | $-28,203 | $-32,770 | $-37,712 | $-36,683 | $-38,837 |